Century Therapeutics, Inc.

IPSC

Century Therapeutics, Inc.

IPSC

Insider Sentiment (TTM):

Last Purchase:2025-12-22Last Sale:2026-06-12Shares Purchased (TTM):145,060Shares Sold (TTM):63,726

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:136,996,706Shares Outstanding:193,474,913Institutional Ownership Pct.:70.81%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	50	51	62	56	57	52	58	53	41	47	47	55
Short Term Investments	70	84	55	77	99	113	131	146	155	145	125	114
Prepaid Expense And Other Assets Current	5	4	4	5	4	5	5	8	7	8	4	4
Assets Current	125	139	121	138	160	170	194	206	203	200	177	174
Property Plant And Equipment Net	34	48	50	54	57	60	62	65	69	69	72	82
Operating Lease Right Of Use Asset	14	21	16	17	28	28	29	29	29	19	20	25
Restricted Cash Noncurrent	2	2	2	2	3	3	3	3	3	2	2	2
Long Term Investments	77	82	-	-	3	21	31	47	73	58	89	115
Goodwill	-	-	-	-	-	-	-	5	5	-	-	-
Intangible Assets Net Excluding Goodwill	34	34	34	34	34	34	34	34	33	-	-	-
Deposits Assets Noncurrent	0	0	0	0	1	1	1	1	1	1	1	1
Assets	287	327	224	245	285	316	353	389	416	349	361	398
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	5	3	5	3	3	4	3	3	3	3	3	6
Business Combination Contingent Consideration Liab…	-	2	4	8	-	-	-	-	-	-	-	-
Deposit Liability Current	-	-	0	0	0	-	0	0	0	0	1	1
Deferred Revenue Current	-	-	-	-	-	-	109	4	4	5	4	4
Liabilities Current	15	14	20	22	15	15	130	20	19	16	18	20
Operating Lease Liability Noncurrent	35	44	40	41	47	48	49	51	53	44	47	46
Security Deposit Liability	-	-	-	-	-	-	-	0	0	0	-	-
Deferred Revenue Noncurrent	-	-	-	-	-	-	-	110	110	110	111	112
Business Combination Contingent Consideration Liab…	-	-	-	1	9	9	9	9	9	-	-	-
Deferred Income Tax Liabilities Net	4	4	4	4	4	4	4	4	3	-	-	-
Liabilities	55	62	65	68	75	75	192	193	194	171	176	178
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,081	1,079	951	949	948	946	943	941	937	862	840	837
Retained Earnings Accumulated Deficit	-848	-814	-792	-773	-738	-706	-782	-746	-715	-684	-656	-616
Accumulated Other Comprehensive Income Loss Net Of…	-1	-1	0	0	0	0	0	1	-0	-0	0	-1
Stockholders Equity	232	265	159	176	210	240	161	196	222	178	185	219
Liabilities And Stockholders Equity	287	327	224	245	285	316	353	389	416	349	361	398
Preferred Stock Par Or Stated Value Per Share	-	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	-	-	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	-	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	-	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	125
Common Stock Shares Issued	181	180	88	87	86	86	86	85	85	65	60	60
Shares Outstanding	181	180	88	87	86	86	86	85	85	60	60	60

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-6.58%	6.58%	-3.95%	-	-	-	-	-	-	-	-	-
2025	19.15%	7.35%	2.90%	-8.18%	-6.73%	6.00%	13.12%	113.98%	308.60%	-14.80%	-7.60%	-2.00%
2024	-2.30%	-16.12%	-17.76%	-2.22%	-10.56%	-22.78%	29.32%	-21.80%	-32.33%	-17.67%	-7.89%	5.66%
2023	-	-	-	-	-	-	2.16%	138.85%	203.60%	-19.51%	-32.82%	-34.15%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.28	10.25	5.97	6.25	10.72	11.70	1.50	10.39	10.62	12.44	9.92	8.50
Quick Ratio	7.94	9.94	5.79	6.03	10.43	11.39	1.46	10.00	10.25	11.95	9.68	8.29
Working Capital	109.70M	125.47M	100.54M	115.68M	145.22M	155.13M	64.27M	186.19M	184.32M	183.75M	159.15M	153.27M
Leverage & Debt
Debt to Equity	0.24	0.23	0.41	0.39	0.36	0.31	1.19	0.99	0.88	0.96	0.95	0.81
Interest Coverage TTM	-	-	-	-	-	-	-	-267.81	-134.68	-119.88	-90.46	-126.01
Debt Ratio	0.19	0.19	0.29	0.28	0.26	0.24	0.54	0.50	0.47	0.49	0.49	0.45
Efficiency & Turnover
Asset Turnover TTM	0.38	0.34	0.76	0.71	0.33	0.35	0.02	0.01	0.00	0.00	0.01	0.01
Per Share Metrics
Diluted EPS TTM	-0.53	-0.56	-0.11	-0.31	-0.27	-0.25	-1.61	-1.53	-1.60	-2.14	-2.30	-2.17
Free Cash Flow Per Share TTM	-0.47	-0.50	-1.21	-0.90	-0.94	-1.34	-1.41	-1.38	-1.35	-1.71	-1.86	-1.83
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-107.17%	-105.46%	-7.91%	-15.12%	-28.13%	-28.02%	-1,681.52%	-5,386.03%	-7,123.02%	-10,640.44%	-6,556.87%	-5,469.86%
Net Profit Margin TTM	-100.58%	-98.74%	-4.39%	-11.81%	-20.11%	-18.83%	-1,540.67%	-4,837.73%	-6,434.23%	-9,742.41%	-6,115.12%	-5,183.16%
Growth Metrics
Net Revenue Growth (1Y)	-5.69%	-6.32%	2,557.67%	8,247.34%	5,568.61%	8,405.40%	267.56%	7.92%	-55.26%	-76.63%	-57.01%	-46.81%
Net Income Growth (1Y)	371.66%	391.18%	-92.43%	-79.62%	-82.28%	-83.56%	-7.40%	0.73%	3.47%	7.05%	4.38%	-11.55%
EPS Growth (1Y)	97.67%	118.39%	-93.12%	-80.03%	-83.13%	-88.09%	-30.16%	-29.31%	-25.32%	0.71%	1.64%	-13.74%
Valuation Metrics
P/E TTM	-4.59	-4.06	-8.99	-1.63	-2.07	-1.87	-0.63	-1.12	-1.59	-1.95	-1.44	-0.92
P/B TTM	2.17	1.65	0.54	0.24	0.23	0.17	0.49	0.74	0.94	1.46	1.07	0.54
P/S TTM	4.62	4.01	0.39	0.19	0.42	0.35	9.67	53.95	102.51	190.07	88.11	47.79
Market Cap	504.16M	437.25M	86.12M	43.06M	48.21M	40.95M	79.44M	144.84M	209.34M	260.40M	196.92M	118.90M
Enterprise Value	452.16M	383.50M	21.11M	-15.61M	-11.38M	-13.69M	18.22M	89.41M	165.04M	211.61M	147.62M	61.61M
Calculated Values
Free Cash Flow TTM	-97.34M	-95.79M	-105.04M	-78.23M	-80.78M	-115.25M	-110.94M	-116.96M	-110.53M	-106.68M	-110.11M	-109.04M
Net Debt	-52.00M	-53.76M	-65.01M	-58.67M	-59.59M	-54.64M	-61.21M	-55.43M	-44.29M	-48.79M	-49.30M	-57.29M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-12Sale

Owner: Carr, Douglas

Title: SVP Finance & Operations

Shares: 1,654

Price/Share: $2.23

Value: $3,688.42

Shares Owned: 505,094

Relationship: Officer

Ownership: Direct

2026-06-12Sale

Owner: Russotti, Gregory

Title: See Remarks

Shares: 2,584

Price/Share: $2.23

Value: $5,762.32

Shares Owned: 512,319

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Russotti, Gregory

Title: See Remarks

Shares: 524

Price/Share: $2.11

Value: $1,105.64

Shares Owned: 514,903

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Carr, Douglas

Title: SVP Finance & Operations

Shares: 249

Price/Share: $2.11

Value: $525.39

Shares Owned: 506,748

Relationship: Officer

Ownership: Direct

2026-05-04Sale

Owner: Carr, Douglas

Title: SVP Finance & Operations

Shares: 264

Price/Share: $2.34

Value: $617.76

Shares Owned: 506,997

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	1,654	2.23	$3,688.42	505,094	4
2026-06-12	Russotti, Gregory	Officer	See Remarks	Direct	Sale	2,584	2.23	$5,762.32	512,319	4
2026-06-08	Russotti, Gregory	Officer	See Remarks	Direct	Sale	524	2.11	$1,105.64	514,903	4
2026-06-08	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	249	2.11	$525.39	506,748	4
2026-05-04	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	264	2.34	$617.76	506,997	4
2026-03-12	Russotti, Gregory	Officer	See Remarks	Direct	Sale	10,076	2.55	$25,693.80	515,427	4
2026-03-12	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	7,043	2.55	$17,959.65	507,261	4
2026-03-09	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	247	2.54	$627.38	514,304	4
2026-03-09	Russotti, Gregory	Officer	See Remarks	Direct	Sale	479	2.54	$1,216.66	525,503	4
2026-02-03	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	323	1.82	$587.86	514,551	4
2025-12-22	Cowan, Chad	Officer	Chief Scientific Officer	Direct	Purchase	58,060	0.85	$49,351.00	1,045,087	4
2025-12-12	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Purchase	52,000	0.58	$30,160.00	3,322,990	4
2025-12-08	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	257	0.53	$136.21	404,874	4
2025-12-08	Russotti, Gregory	Officer	See Remarks	Direct	Sale	526	0.53	$278.78	390,982	4
2025-11-20	Cowan, Chad	Officer	Chief Scientific Officer	Direct	Sale	5,462	0.50	$2,731.00	987,027	4
2025-11-19	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Purchase	35,000	0.50	$17,500.00	3,271,453	4
2025-11-17	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Sale	32,456	0.45	$14,605.20	3,236,453	4
2025-11-03	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	292	0.59	$172.28	405,131	4
2025-09-08	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Sale	488	0.50	$244.00	3,268,909	4
2025-09-08	Russotti, Gregory	Officer	See Remarks	Direct	Sale	539	0.50	$269.50	391,508	4
2025-09-08	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	263	0.50	$131.50	405,423	4
2025-08-04	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	296	0.53	$156.88	405,686	4
2025-06-09	Russotti, Gregory	Officer	See Remarks	Direct	Sale	526	0.62	$326.12	392,047	4
2025-06-09	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Sale	475	0.62	$294.50	1,681,783	4
2025-06-09	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	4,904	0.62	$3,040.48	405,982	4
2025-06-09	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	552	0.62	$342.24	250,141	4
2025-05-16	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Sale	29,552	0.55	$16,253.60	1,682,258	4
2025-05-05	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	1,024	0.55	$563.20	250,693	4
2025-05-05	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	295	0.55	$162.25	410,886	4
2025-03-10	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	1,240	0.62	$768.80	315,556	4
2025-03-10	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Sale	2,235	0.62	$1,385.70	1,190,310	4
2025-03-10	Russotti, Gregory	Officer	See Remarks	Direct	Sale	2,360	0.62	$1,463.20	272,573	4
2025-03-10	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	2,359	0.62	$1,462.58	131,717	4
2025-02-18	Pfeiffenberger, Brent	Director,Officer	President and CEO	Direct	Sale	34,712	0.78	$27,075.36	1,192,545	4
2025-02-03	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	351	0.78	$273.78	316,796	4
2025-02-03	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	1,054	0.78	$822.12	134,076	4
2024-11-04	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	1,033	1.23	$1,270.59	135,130	4
2024-11-04	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	283	1.23	$348.09	317,147	4
2024-09-12	Quimi, Daphne	Director	-	Direct	Purchase	5,000	1.53	$7,650.00	5,000	4
2024-08-05	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	289	1.83	$528.87	334,041	4
2024-08-05	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	1,073	1.83	$1,963.59	136,163	4
2024-07-26	Russotti, Gregory	Officer	See Remarks	Direct	Sale	586	2.50	$1,465.00	274,933	4
2024-07-24	Russotti, Gregory	Officer	See Remarks	Direct	Sale	1,600	2.52	$4,032.00	275,519	4
2024-06-20	Russotti, Gregory	Officer	See Remarks	Direct	Sale	5,000	2.84	$14,200.00	277,319	4
2024-06-05	Russotti, Gregory	Officer	See Remarks	Direct	Sale	5,000	3.00	$15,000.00	282,319	4
2024-05-20	Russotti, Gregory	Officer	See Remarks	Direct	Sale	5,000	3.00	$15,000.00	287,319	4
2024-05-06	Russotti, Gregory	Officer	See Remarks	Direct	Sale	5,000	3.12	$15,600.00	292,319	4
2024-05-03	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	257	3.11	$799.27	317,323	4
2024-05-03	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	913	3.11	$2,839.43	137,236	4
2024-04-22	Russotti, Gregory	Officer	See Remarks	Direct	Sale	5,000	3.10	$15,500.00	297,319	4
2024-03-07	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	22,831	5.14	$117,351.34	114,149	4
2024-02-16	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	485	4.86	$2,357.10	114,149	4
2024-02-06	Farid, Adrienne	Officer	Chief Operations Officer	Direct	Sale	1,784	4.49	$8,010.16	114,149	4
2024-02-06	Carr, Douglas	Officer	SVP Finance & Operations	Direct	Sale	557	4.49	$2,500.93	303,580	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

70.81%

Inst. Shares: 136,996,706

Shares Outstanding: 193,474,913

2025-12-31

27.83%

Inst. Shares: 24,087,224

Shares Outstanding: 86,556,515

2025-09-30

21.91%

Inst. Shares: 18,940,255

Shares Outstanding: 86,464,066

2025-06-30

25.12%

Inst. Shares: 21,661,220

Shares Outstanding: 86,238,084

2025-03-31

33.92%

Inst. Shares: 29,174,320

Shares Outstanding: 86,021,188

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	136,996,706	193,474,913	70.81%
2025-12-31	24,087,224	86,556,515	27.83%
2025-09-30	18,940,255	86,464,066	21.91%
2025-06-30	21,661,220	86,238,084	25.12%
2025-03-31	29,174,320	86,021,188	33.92%
2024-12-31	36,134,911	78,648,958	45.94%
2024-09-30	39,422,678	84,704,352	46.54%
2024-06-30	38,088,375	82,092,167	46.40%
2024-03-31	22,917,131	62,296,637	36.79%
2023-12-31	17,457,480	59,314,389	29.43%
2023-09-30	17,876,288	59,448,229	30.07%
2023-06-30	19,115,941	59,251,363	32.26%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Century Therapeutics, Inc. (IPSC) — SEC Financial Statements & Analysis

Century Therapeutics, Inc. (IPSC) is a biological products, (no diagnostic substances) company, incorporated in DE. Century Therapeutics, Inc. trades on Nasdaq as: IPSC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Century Therapeutics, Inc. reported a -5.69% year-over-year revenue growth, a Debt-to-Equity ratio of 0.24x, a Price-to-Sales (P/S) ratio of 4.62x (TTM), a Price-to-Book (P/B) ratio of 2.17x (TTM), at a market cap of $504.16M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -5.69%
Debt To Equity: 0.24x
P/S TTM: 4.62x
P/B TTM: 2.17x
Market Cap: $504.16M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Century Therapeutics, Inc. in?

Century Therapeutics, Inc. (IPSC) operates in the Biological Products, (No Diagnostic Substances) industry.

What is IPSC's market cap?

Century Therapeutics, Inc. (IPSC) has a market capitalization of $504.16M as of 2026-06-30.

What exchange does IPSC trade on?

Century Therapeutics, Inc. (IPSC) trades on the Nasdaq.

Where is Century Therapeutics, Inc. incorporated?

Century Therapeutics, Inc. is incorporated in DE.